Chief Legal Officer Alexis M. Pinto resigns from Zentalis, effective July 5, 2022

Zentalis Pharmaceuticals, Inc.

Alexis M. Pinto notified resignation as Chief Legal Officer and Secretary on June 21, 2022.
Resignation effective July 5, 2022; no successor named.
Company filed Form 8-K on June 27, 2022, to report the departure.
No reason for departure disclosed in the filing.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Alexis M. Pinto

Chief Legal Officer and Secretary

ZNTL · Zentalis Pharmaceuticals, Inc.

Effective: 2022-07-05
Filed: June 27, 2022, 7:59 PM ET

On June 21, 2022, Alexis M. Pinto notified Zentalis Pharmaceuticals, Inc. (the “Company”) of her resignation as Chief Legal Officer and Secretary of the Company, effective as of July 5, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Alexis M. Pinto resigned as Chief Legal Officer and Secretary at Zentalis Pharmaceuticals, Inc..

Action: resigned
Role: Chief Legal Officer and Secretary

Exact text from the filing

On June 21, 2022, Alexis M. Pinto notified Zentalis Pharmaceuticals, Inc. (the “Company”) of her resignation as Chief Legal Officer and Secretary of the Company, effective as of July 5, 2022.

View on SEC.gov

Zentalis Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001725160-22-000129

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.